239 related articles for article (PubMed ID: 21289304)
1. OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.
So T; Choi H; Croft M
J Immunol; 2011 Mar; 186(6):3547-55. PubMed ID: 21289304
[TBL] [Abstract][Full Text] [Related]
2. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.
Mousavi SF; Soroosh P; Takahashi T; Yoshikai Y; Shen H; Lefrançois L; Borst J; Sugamura K; Ishii N
J Immunol; 2008 Nov; 181(9):5990-6001. PubMed ID: 18941188
[TBL] [Abstract][Full Text] [Related]
3. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
4. Constitutively active protein kinase B enhances Lck and Erk activities and influences thymocyte selection and activation.
Na SY; Patra A; Scheuring Y; Marx A; Tolaini M; Kioussis D; Hemmings BA; Hünig T; Bommhardt U
J Immunol; 2003 Aug; 171(3):1285-96. PubMed ID: 12874217
[TBL] [Abstract][Full Text] [Related]
5. Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.
So T; Soroosh P; Eun SY; Altman A; Croft M
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2903-8. PubMed ID: 21282629
[TBL] [Abstract][Full Text] [Related]
6. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
Finney HM; Akbar AN; Lawson AD
J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
[TBL] [Abstract][Full Text] [Related]
7. Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.
Tran CW; Saibil SD; Le Bihan T; Hamilton SR; Lang KS; You H; Lin AE; Garza KM; Elford AR; Tai K; Parsons ME; Wigmore K; Vainberg MG; Penninger JM; Woodgett JR; Mak TW; Ohashi PS
J Immunol; 2017 Dec; 199(12):4056-4065. PubMed ID: 29109121
[TBL] [Abstract][Full Text] [Related]
8. The role of OX40-mediated co-stimulation in T-cell activation and survival.
Redmond WL; Ruby CE; Weinberg AD
Crit Rev Immunol; 2009; 29(3):187-201. PubMed ID: 19538134
[TBL] [Abstract][Full Text] [Related]
9. Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
Redmond WL; Triplett T; Floyd K; Weinberg AD
PLoS One; 2012; 7(4):e34467. PubMed ID: 22496812
[TBL] [Abstract][Full Text] [Related]
10. A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions.
Lathrop SK; Huddleston CA; Dullforce PA; Montfort MJ; Weinberg AD; Parker DC
J Immunol; 2004 Jun; 172(11):6735-43. PubMed ID: 15153490
[TBL] [Abstract][Full Text] [Related]
11. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
Kim EY; Teh HS
J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
[TBL] [Abstract][Full Text] [Related]
12. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
13. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer.
Redmond WL; Weinberg AD
Crit Rev Immunol; 2007; 27(5):415-36. PubMed ID: 18197805
[TBL] [Abstract][Full Text] [Related]
14. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.
Maxwell JR; Weinberg A; Prell RA; Vella AT
J Immunol; 2000 Jan; 164(1):107-12. PubMed ID: 10605000
[TBL] [Abstract][Full Text] [Related]
15. Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2007 Oct; 179(8):5014-23. PubMed ID: 17911586
[TBL] [Abstract][Full Text] [Related]
16. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
17. Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex.
Bjørgo E; Solheim SA; Abrahamsen H; Baillie GS; Brown KM; Berge T; Okkenhaug K; Houslay MD; Taskén K
Mol Cell Biol; 2010 Apr; 30(7):1660-72. PubMed ID: 20086095
[TBL] [Abstract][Full Text] [Related]
18. OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.
Goulding J; Tahiliani V; Salek-Ardakani S
Immunol Rev; 2011 Nov; 244(1):149-68. PubMed ID: 22017437
[TBL] [Abstract][Full Text] [Related]
19. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
20. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
